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We investigated the nuclear localization-like sequence KKRPKP, corresponding to the residues 23–28 in the mouse prion protein (mPrP), for
its membrane perturbation activity, by comparing effects of two mPrP-derived peptides, corresponding to residues 1–28 (mPrPp(1–28)) and 23–
50 (mPrPp(23–50)), respectively. In erythrocytes, mPrPp(1–28) induced ∼60% haemoglobin leakage after 30 min, whereas mPrPp(23–50) had
negligible effects. In calcein-entrapping, large unilamellar vesicles (LUVs), similar results were obtained. Cytotoxicity estimated by lactate
dehydrogenase leakage from HeLa cells, was found to be ∼12% for 50 μM mPrPp(1–28), and ∼1% for 50 μM mPrPp(23–50). Circular
dichroism spectra showed structure induction of mPrPp(1–28) in the presence of POPC:POPG (4:1) and POPC LUVs, while mPrPp(23–50)
remained a random coil. Membrane translocation studies on live HeLa cells showed mPrPp(1–28) co-localizing with dextran, suggesting fluid-
phase endocytosis, whereas mPrPp(23–50) hardly translocated at all. We conclude that the KKRPKP-sequence is not sufficient to cause
membrane perturbation or translocation but needs a hydrophobic counterpart.
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Transmissible spongiform encephalopathies (TSEs), also
known as prion diseases, are fatal neurological disorders of
humans and animals that can occur sporadically, by infection, or
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doi:10.1016/j.bbamem.2007.09.034conversion of the cellular form of the neural prion protein
(PrPC), into an infectious scrapie isoform (PrPSc) [1–3]. The
conversion is posttranslational and mutations of the primary
amino acid sequence are not needed for the conversion to take
place. PrPSc forms insoluble aggregates that show high re-
sistance to proteinase K digestion, whereas PrPC is monomeric
and is readily digested via proteolytic processes [4].
The prion protein consists of an unstructured N-terminal
domain (composed of a signal peptide (1–22) in the mouse
protein), a basic region (23–28), a preoctarepeat region (29–50),
an octarepeat region (51–105) prone to bind copper-ions, and a
hydrophobic stretch (106–125), a globular C-terminal domain
(126–231) comprised of three α-helices and two β-turns, and a
C-terminal signal peptide (232–254) [5].
The full length prion protein is rarely examined together with
its signal peptide (residues 1–22) since the signal peptide part is
normally cleaved off during maturation. It has however been
shown that in some cases this part can be retained [6], and that
this particular sequence might be associated with functions such
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that the uncleaved signal peptide could cause the prion protein
to change its conformation and thus become neurotoxic [6,9].
Hypothetically the mature PrPC might even play a neuropro-
tective role, reversing neurotoxicity induced by the doppel
(Dpl) protein, which is a PrP homologue. Deletion of the
charged region PrPΔ(23–28) left the mutated PrP incapable of
rescuing cerebellar neurons in transgenic mice [5].
The signal peptide is by itself hydrophobic and relatively
insoluble in water, but taken together with the highly positive,
nuclear localization-like (NLS-like) [10] KKRPKP-sequence
(residues 23–28), it becomes water soluble. The corresponding
peptide has a sequence that resembles the composition of certain
primary amphipathic cell-penetrating peptides (CPPs). These
peptides have a primary structure that contains distinct hydro-
phobic and hydrophilic regions. Transportan (a chimeric pep-
tide composed of galanin interlinked with mastoparan by a
lysine) and MAP (an amphipathic model peptide) are two well-
known CPPs that are considered to be members of the above
mentioned class [11–14]. CPPs, also known as protein trans-
duction domains (PTDs), in general have been used as trans-
membrane delivery vectors of hydrophilic molecules. Different
mechanisms have been debated, but endocytosis followed by
endosomal escape seems to dominate. There have been few
sequence similarities found between different classes of CPPs,
but nevertheless attempts to predict CPPs based on bulk prop-
erties of the constituent amino acids have been conducted with
fair success [15]. The most common definitions of CPPs include
a length restriction around 30 amino acids, a net positive charge
and often either primary or secondary amphipathicity.
It has been shown that both the bovine and the mouse prion
protein-derived peptides (abbreviated bPrPp(1–30), and mPrPp
(1–28) respectively) can translocate over cell membranes even
when coupled to large hydrophilic cargoes. Concomitantly these
peptides cause cell toxicity and are thus not good candidates as
useful CPPs [9,16]. However, the capability of crossing bio-
membranes suggests a plausible explanation for how oral prion
infection might occur in vivo; an unprocessed PrP could in
theory cross physiological barriers – like the gut epithelium or
the blood brain barrier (BBB) – via a process where the CPP-like
part of the protein would drag the rest of the prion protein (or an
aggregated form of it) along as cargo. This type of in vivo protein
transduction through the BBB has been demonstrated earlier for
the Tat-β-galactocidase fusion protein (120 kDa) [17]. The Tat-
peptide is a CPP derived from the protein transduction domain of
the human immunodeficiency virus 1 (HIV-1) Tat protein [18].
This study focuses on the relevance of the NLS-like part of
the PrP, i.e. residues 23–28 forming the KKRPKP-sequence. ATable 1
The peptide sequences examined in this study are given together with their average hy
Peptide Sequence
Melittin GIGAVLKVLTTGLPALISWIKRKRQQ
mPrPp(1–28) MANLGYWLLALFVTMWTDVGLCKKRP
Penetratin RQIKIWFQNRRMKWKK
mPrPp(23–50) KKRPKPGGWNTGGSRYPGQGSPGGNRT
Aromatic residues are written in bold, while charged residues are underlined.new peptide, denoted mPrPp(23–50) (see Table 1 for peptide
sequences), with the same length as mPrPp(1–28) and con-
taining the KKRPKP-sequence was constructed. Its properties
are compared to mPrPp(1–28) regarding membrane perturba-
tion and translocation ability, both in membrane mimetic and
living cell systems. The KKRPKP-sequence has been suggested
to guide the cellular trafficking of PrP and to be responsible for
direct internalization of the prion protein via endocytosis [19].
A recent study also shows that the PrP(23–30) sequence can
selectively bind to PrPSc and not to PrPC [20].
The present results that show great differences between the
high and low membrane perturbing activites of mPrPp(1–28)
and mPrPp(23–50), respectively, indicate that the KKRPKP
segment may be necessary, but is not sufficient for the mem-
brane perturbing activites of the unstructured part of PrP.
2. Materials and methods
2.1. Materials
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-palmi-
toyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] sodium salt (POPG)
were purchased from Avanti Polar Lipids, Alabaster, of best quality and used
without further purification. Triton X-100 was obtained from Sigma. The pre-
packed PD-10 Columns, Sephadex™ G-25 M, were obtained from Amersham
Biosciences. Calcein, a fluorescein derivative, was purchased from Molecular
Probes, The Netherlands (product no. C-481). 5(6)-carboxyfluorescein and
rhodamine-B-labelled dextran (70 kDa) were obtained from the same company.
The peptides (without fluorescent labels) were either purchased from
Neosystem Laboratorie (Strasbourg, France) and used without further pu-
rification, or synthesized on a peptide synthesizer from Applied Biosystems
(model 431A, USA). The tert-Butyloxycarbonyl amino acids and the para-
methylbenzylhydrylamine (MBHA) resin were also acquired from Neosystem
Laboratorie. Table 1 shows the sequences, relative hydrophobicities and Gibbs
free energies of the studied peptides.
HeLa cells were obtained from the American Type Culture Collection
(Manassas, USA). The cells were cultivated in Dulbecco's modified essential
medium (DMEM) supplemented with 10% fetal bovine serum, 2 mM L-
glutamine, 100 U ml−1 penicillin and 100 μg ml−1 streptomycin. All cell culture
reagents were purchased from Invitrogen (Stockholm, Sweden).
2.2. Peptide synthesis, purification and analysis
2.2.1. Peptide synthesis and carboxyfluorescein labelling
The amino acids were linked in a stepwise manner in a 0.1 mmol scale on a
peptide synthesizer using t-Boc strategy of solid phase peptide synthesis. tert-
Butyloxycarbonyl amino acids were coupled as hydroxybenzotriazole (HOBt)
esters to a p-methylbenzylhydrylamine (MBHA) to obtain C-terminally ami-
dated peptides. The peptides were fluorescein labelled by the use of 5 molar
equivalents of 5(6)-carboxyfluorescein, 5 molar equivalents of DIC, 5 molar
equivalents of HOBt and 20 molar equivalents of DIEA in DMF (dimethyl-
formamide) overnight. Deprotection of the formyl protecting group on tryp-
tophan was carried out in 20% piperidine in DMF during 60 min. The peptidesdrophobicities calculated according to values devised by Kyte and Doolittle [33]
Net charge Hydrophobicity
+5 0.27
KP +3 0.30
+7 −1.73
P +6 −1.86
208 K. Oglęcka et al. / Biochimica et Biophysica Acta 1778 (2008) 206–213were finally cleaved from the solid phase with HF (hydrogen fluoride) at 0 °C
during 1 h in the presence of p-cresol, or p-cresol and p-thiocresol (1:1) if the
peptide sequence contained cysteine or methionine residues.
2.2.2. HPLC purification and analysis of synthesized peptides
The cleaved peptides were purified using a reversed-phase HPLC Iomega
C18 column and analyzed using a Perkin Elmer prOTOF™ 2000 MALDI O-
TOF mass spectrometer.
2.2.3. Determination of peptide concentration
Peptides were dissolved in distilled water and the concentration of the
solutions was established using a quartz cuvette of 1 cm path length in a CARY 4
spectrophotometer at 280 nm. The molar extinction coefficients used were
5690M−1 cm−1 for tryptophan, 1280M−1 cm−1 for tyrosine, and 120M−1 cm−1
for cysteine [21].
2.3. Large unilamellar vesicles
2.3.1. Preparation of LUVs
Large unilamellar vesicles (LUVs) were prepared by dissolving the phospho-
lipids POPC and POPG (in a desired molar ratio) in chloroform. The solution was
vortexed in order to ensure propermixing of the components, and the chloroformwas
evaporated using argon gas. The remaining lipid filmwas then placed under vacuum
for a minimum time of 1 h in order to ensure the complete removal of residual
chloroform. The dried lipid film was dispersed in 50 mM potassium phosphate
buffer, pH7.4, by vortexing (10min) resulting in a final lipid concentration of either 1
or 10mM(based onweight to volume). The dispersionwas freeze–thawed five times
using liquid nitrogen/hot water and then passed through two membranes of 100 nm
pore size 21 times using a pneumatic Avanti extruder. The vesicles were kept on ice
when not involved in measurements and always used within 24 h.
2.3.2. Preparation of calcein-entrapping LUVs
A 55 mM calcein solution in 50 mM potassium phosphate buffer pH 7.4 was
prepared. The solution was passed once through two 100 nm pore sized
membranes before it was used to disperse a dried lipid film of desired
composition. The resulting 10 mM lipid dispersion was vortexed, freeze–
thawed and extruded as described above. The formed calcein-entrapping
vesicles were passed through three sequential Sephadex-G25 columns in order
to remove the non-entrapped calcein. The dilution factor of each column is
estimated to be ∼1.5 according to the manufacturer.
2.4. Steady-state fluorescence spectroscopy
The calcein leakage measurements were conducted on a Perkin Elmer LS
50B Luminescence Spectrometer using FL WinLab software. The experiments
were run at room temperature in a 4×10 mm quartz cuvette. The samples were
excited at 490 nm and their emission was scanned from 510 to 600 nm. The scan
speed was 250 nm/min and the bandwidth for both excitation and emission was
set to 4 nm. Each spectrum was baseline corrected and averaged over five
accumulated scans. The fluorescence of calcein is well self-quenched at 55 mM.
2.4.1. Peptide-induced calcein leakage from calcein-entrapping LUVs
Calcein-entrapping LUVs POPC:POPG (4:1) were diluted with 50 mM
potassium phosphate buffer pH 7.4 to a phospholipid concentration of∼400 μM
and 750 μl was used for each experiment. Each peptide (stock solution 100 μM)
was titrated into the sample (3 μl at a time) with an incubation time of 3 min
preceding each measurement. The vesicles were lysed with 5 μl of 10% (v/v)
Triton X-100 at the end of each titration series in order to establish the maximum
fluorescence intensity corresponding to each sample. The % leakage was de-
termined according to:
k leakage ¼ 100 F  F0
Fmax  F0
 
where F0 represents the background fluorescence, Fmax the fluorescence after
lysis of the vesicles, and F the fluorescence upon 3 min incubation of the
vesicles with the peptide.2.5. Spectrophotometry
For the measurement of haemoglobin leakage, a CARY 4 Spectrophotom-
eter was used combined with a quartz cuvette with a 1 cm light path. The
absorption was measured at the haemoglobin absorption maximum of 540 nm
and averaged over three measurements.
2.5.1. Peptide-induced haemoglobin leakage from hRBCs
Peptides were tested for haemolytic activity against human red blood cells
(hRBCs) taken from fresh venous blood. The hRBCs were washed three times
with buffer (150 mM NaCl, 0.1 mM EDTA, 20 mM Tris, pH 7.4) by
centrifugation (10 min, 3000 rpm, 10 °C) and re-suspension. The rinsed blood
cells were then diluted with buffer to a concentration of about 5% v/v hRBCs,
(haematocrit) and distributed to 15 ml falcon tubes (1 ml of diluted blood in
each). Peptides (10 μM) were added to the falcon tubes and incubated for
different time periods during rocking at room temperature. The blood was then
centrifuged again (2 min, 3000 rpm, 10 °C) and the supernatant was analyzed
by spectrophotometry as described above. 0% and 100% haemolytic activity
was defined by the absorption of the supernatant of hRBCs suspended in buffer
and water respectively. The apparent percentage haemolysis was calculated
according to:
k haemolysis ¼ 100 At  A0
Amax  A0
 
where A0 is the background absorption level, Amax the level after cell lysis, and
At the measured absorption at time t after addition of the peptide.
2.6. Circular dichroism spectroscopy (CD)
CD measurements were conducted on a Jasco-750 CD Spectropolarimeter
with a 1 mm quartz cuvette. The spectra were acquired from 260 to 190 nm with
a data pitch of 1 nm. The scanning speed was 50 nm/min, the response time 1 s
and the slit width 2 nm. Each spectrum was background corrected and averaged
over 15 accumulated scans. The mean residual molar ellipticities were calculated
with respect to peptide concentration, light path length and number of residues.
The LUVs (POPC:POPG (4:1) or POPC) where diluted with 50 mM phosphate
buffer, pH 7.4, to a total lipid concentration of 100 μM. Peptides (total
concentration 20 μM) were incubated at room temperature for 30 min with the
LUVs before measurements. Reference spectra were run in water and buffer. All
experiments were conducted at 25 °C.
2.7. Peptide translocation and toxicity studies on HeLa cells
2.7.1. Co-localization of mPrPp(1–28) and mPrPp(23–50) with dextran in live
HeLa cells
HeLa cells were seeded in NUNC 8-well chambers and one day post
seeding, at an 80% confluence, the cells were washed with serum-free DMEM,
followed by the addition of the peptides at a final concentration of 2 μM. After
30 min incubation, the cells were washed three times with HKR (Hepes
buffered Krebs–Ringer) buffer (containing 125 mM NaCl, 3.5 mM KCl,
1.5 mM CaCl2, 1.2 mMMgSO4, 1.25 mM KH2PO4, 25 mM NaHCO3, 10 mM
HEPES, and 10 mM D-glucose, pH 7.4). After washing, fluoresceinyl-labelled
peptide and rhodamine-B-labelled dextran were added simultaneously at a final
concentration of 2 μM and 1 mg ml−1, respectively. After 30 min incubation in
serum-free DMEM at 37 °C, the cells were washed three times with HKR buffer
and examined using UltraView ERS confocal live cell imager (PerkinElmer
Ltd, Upplands-Väsby, Sweden) connected to an Axiovert 200 (Zeiss,
Göttingen, Germany). Negative controls were made without the presence of
dextran.
2.7.2. Cytotoxicity of prion protein-derived peptides measured by LDH leakage
HeLa cells were seeded out in 48-well plates 2 days before the ex-
periments, and at 80% confluency the membrane integrity was assessed using
the Promega Cytox-ONE™ assay. Cytotoxicity was expressed as the percent
extracellular lactase dehydrogenase (LDH) activity out of the total LDH
activity measured after cell lysis. HeLa cells were incubated with different
Fig. 1. The induced calcein leakage in 400 μM POPC:POPG (4:1) LUVs, pH
7.4. 3 μl of 100 μM peptide was added and incubated for 3 min before each
measurement. All experiments were conducted at room temperature.
Fig. 3. The percentual cytotoxicity of four different peptides based on lactate
dehydrogenase (LDH)-leakage in HeLa cells. The incubation time was 30 min at
37 °C for all measurements. The enzyme activity after peptide treatment was
expressed as the percentage of extracellular LDH activity as compared to the
total LDH activity measured upon cell lysis. The standard error of mean was
calculated based on three independent duplicates of experiments.
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PrP-derived peptides were compared to the ones of penetratin and melittin.
The experiments were repeated three times on independent duplicate cells.
3. Results
Previous studies [22] concerning mPrPp(1–28), penetratin
and melittin in partially charged large unilamellar vesicles
(LUVs) showed significant differences in their abilities to cause
leakage of vesicle entrapped calcein. Melittin is the main
constituent of the toxin from honeybee, Apis mellifera, and
known to be a very potent membrane perturbing peptide [23].
Penetratin is a relatively non-toxic, but efficient CPP [24].
Melittin was found to cause rapid and complete calcein leakage
in the LUVs, followed by mPrPp(1–28) with intermediate
activity, and penetratin being relatively inert [22]. In the present
study we investigated the effects of mPrPp(23–50) in a similar,
partially negatively charged membrane model system compar-
ing the results to mPrPp(1–28) and penetratin. The peptide-
induced release of calcein from the calcein-entrapping LUVs is
shown in Fig. 1 as a function of peptide concentration. In theseFig. 2. The percentual haemoglobin leakage from hRBC after incubation with
10 μM peptides during different time periods. Experiments were conducted at
room temperature at pH 7.4.
Fig. 4. (Top) The CD spectra of mPrPp(1–28) and mPrPp(23–50) in water and
50 mM potassium phosphate buffer, pH 7.4. (Bottom) The CD spectra of mPrPp
(1–28) and mPrPp(23–50) with LUVs in the same buffer with either POPC or
POPC:POPG (4:1) content, and a total lipid concentration of 100 μM. All
measurements were conducted at 25 °C after 30 min of incubation with 20 μM
peptide at room temperature.
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vesicle sample, which was incubated for 3 min before each
measurement. As expected, the results show that mPrPp(1–28)
is more potent than penetratin in leakage induction potency. In
contrast to the two peptides which were able to induce vesicle
leakage, mPrPp(23–50) did not give rise to any significant
leakage from the LUVs.
In another experiment, the haemolytic activities of the three
peptides were investigated. Here, the peptide-induced haemo-
globin leakage in human erythrocytes was followed at 10 μM
peptide concentrations. Fig. 2 shows the time course of haemo-
globin leakage for mPrPp(1–28), mPrPp(23–50) and penetra-
tin. Under these conditions there is significant haemoglobin
leakage caused only by mPrPp(1–28). mPrPp(23–50) is even
somewhat less haemolytic than penetratin.
Next we investigated a more complex cell system for the
sensitivity towards the peptides. Lactate dehydrogenase (LDH)
leakage from HeLa cells was used as a measure of the cytotoxic
effects of the two PrP-derived peptides. In this case we chose to
compare the effects to both penetratin and melittin, the latter
used to give a high degree of leakage close to what is observed
after cell lysis. The LDH activity was measured outside the
HeLa cells after an incubation time of 30 min and compared to
the total LDH activity measured upon cell lysis, defining 100%
cytotoxicity. Fig. 3 shows that melittin reaches a level of almost
80% cytotoxicity already at a concentration of 1 μM, whereas
penetratin and mPrPp(23–50) stay at levels of 1–3% at a
concentration of 50 μM. The more active mPrPp(1–28) on the
other hand, reaches levels that could be considered cytotoxic
(i.e. above 10%) at 50 μM concentration, while at 10 μM the
cytotoxicity can still be considered low—around 5%.Fig. 5. Confocal microscopy images of live HeLa cells showing the internalized fluo
internalized, whereas mPrPp(23–50) is just barely internalized. The incubation timeFig. 4 displays the CD spectra of the two mPrP-derived
peptides, 20 μM, in water, 50 mM sodium phosphate buffer pH
7.4, and in the presence of POPC:POPG (4:1) and POPC LUVs
at pH 7.4. No significant change from random coil is induced
by neither buffer nor the presence of vesicles in the case of
mPrPp(23–50) after an incubation time of 30 min. This result
suggests overall very weak (and/or slowly occurring) interac-
tions (if any) with the vesicular membranes, even with the
charged LUVs. mPrPp(1–28) on the other hand, changes its
secondary structure depending on its environment. In water, it
predominantly takes on a random coil structre, while buffer
seems to stabilize an α-helical conformation. In both zwitterionic
and negatively charged LUVs we observe a conversion towards a
mixture of β-sheet and α-helix for mPrPp(1–28). At 50 μM
concentration both peptides have however shown a propensity
towards aggreggation after prolonged room temperature
exposure in buffer containing samples (data not shown).
In order to establish whether the two mPrP-derived peptides
show different translocation abilities upon contact with bio-
logical membranes, confocal fluorescence microscopy was used
to study their internalization potency in live HeLa cells. For
these experiments, fluoresceinyl-labelled peptides had to be
used. Fig. 5 shows the confocal microscopy images of live HeLa
cells together with mPrPp(1–28) in the left column, and mPrPp
(23–50) in the right column. The cells still look intact after
30 min of incubation with both peptides. Distinct fluorescent
spots are visible for mPrPp(1–28), showing membrane translo-
cation into the cells for this peptide, in agreement with previous
studies [9,16]. Under the same conditions for mPrPp(23–50), the
absence of fluorescent spots inside the cells shows that mPrPp
(23–50) has a much weaker ability to enter into the cells.resceinyl-labelled mPrPp(1–28) and mPrPp(23–50). mPrPp(1–28) is effectively
was 30 min at 37 °C and the final peptide concentration 2 μM.
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suggest that the experiment shows a significant difference
between the two peptides in their cell-penetrating ability, with
mPrPp(1–28) being significantly more potent. Further confocal
microscopy experiments with the labelled peptides confirmed
the quantitative difference in their uptake into live HeLa cells
(Fig. S1). These images also showed that mPrPp(1–.28) co-
localizes with dextran, a fluid-phase endocytosis marker,
suggesting fluid-phase endocytosis to be a dominant mechanism
of internalization for this peptide. In some experiments very
small traces of mPrPp(23–50) could be observed inside the
HeLa cells (data not shown), whichmay suggest that this peptide
is internalized by random incorporation of outside materials
during endocytosis.
4. Discussion
In this study we investigate the significance of the basic
KKRPKP-sequence, residues 23–28 of the mouse prion
protein, by constructing a peptide mPrPp(23–50), with this
basic sequence overlapping with mPrPp(1–28). Three types of
experiments to investigate membrane perturbation caused by
mPrPp(23–50) comparing it to mPrPp(1–28) were performed.
Calcein leakage from partially charged LUVs, leakage of
haemoglobin from erythrocytes as well as LDH leakage from
HeLa cells showed very similar patterns: compared to the
rather potent mPrPp(1–28) which had been studied earlier
[22], mPrPp(23–50) was found to be inactive. The parallel
membrane perturbations effects in model systems as well as in
cell systems suggest that despite the obvious differences in
membrane composition in the experiments, there is a
fundamental phospholipid bilayer interaction which may be
the major factor to determine the extent of cell leakage and
toxicity. The behaviour of the prion derived peptides in this
experiment approximately follows the calculated hydropho-
bicity index of respective peptides, as indicated by Table 1.
The positive hydrophobicities of melittin and mPrPp(1–28)
are compatible with their high membrane perturbing activities,
whereas the negative hydrophobicities of penetratin and
mPrPp(23–50) are compatible with their low membrane
perturbing activities, although there is no absolute relationship
between the theoretical indices and the experimental
observations.
The importance of direct membrane perturbation during
an induced cell response, is suggested also from comparing the
membrane perturbation results (Figs. 1–3) to the secondary
structures obtained by CD (Fig. 4). mPrPp(1–28) interactions
with vesicle membranes, uncharged or partially charged, are
seen as changes in secondary structure. The peptide intreracts
with both types of membranes in the same conformation,
suggesting that the mode of action is similar as well. mPrPp
(23–50) does not show any obvious interaction with the
vesicles judging from the lack of structure induction observed
by CD. In itself an unchanged CD spectrum is not a proof of
absence of membrane interaction, since for example the
dynorphin opioid peptides [25,26] are known to translocate
through cell membranes and still retain their random coilformations. We conclude however, that the weak membrane
perturbations exhibited by mPrPp(23–50) in general, are in line
with the absence of secondary structure induction by the vesicle
membranes.
Fig. 5 compares the ability of fluorecein-labelled mPrPp
(1–28) and mPrPp(23–50) to enter into live HeLa cells. Again
mPrPp(23–50) is much less active than mPrPp(1–28). The
mPrPp(1–28) peptide is highly homologous to its bovine coun-
terpart bPrPp(1–30), which has previously been shown to enter
live mammalian CHO cells [16] using macropinocytosis (fluid-
phase endocytosis) as the main mechanism of action. The
same conclusion is drawn here for mPrPp(1–28) based on co-
localization experiment with dextran shown in Fig. S1. The
significantly different membrane perturbation activites of the
mPrPp(1–28) and mPrPp(23–50) correlate well with their re-
spective cell membrane translocation abilities.
The signal sequence of the prion protein, residues 1–22 in
mPrP, is normally cleaved off during maturation, but it has
been shown that this process might fail at times leaving the
signal sequence in place [6]. The retention of the signal
sequence has been suggested to prompt the prion protein's
conformational change from the cellular, benign form, to the
neurotoxic scrapie form [6,9]. In the native protein, the signal
sequence is followed by a basic region (KKRPKP) referred to
as the NLS-like sequence. The results presented in this study
show that in a peptide or unstructured part of a protein the
KKRPKP-sequence in itself is not sufficient to cause potent
membrane perturbations or to mediate cell transloction. We
propose that the KKRPKP-sequence needs a hydrophobic
partner sequence in order to attain membrane perturbation and
translocation properties. One can question whether the
hydrophobic segment has to be adjacent like the signal
peptide (residues 1–22) in the present case, or whether the
membrane activity can be efficiently increased by a hydro-
phobic segment present elsewhere in the protein sequence.
Possibly the putative transmembrane region around residue
115 (still a part of the unstructured N-terminus) could fulfil
this role in PrP. The hydrophobicity of mPrPp(1–28) is higher
than that of mPrPp(23–50) (Table 1) which is in line with the
observation that mPrPp(23–50) has more difficulty to dissolve
itself into the bilayer. Although the net positive charge is
higher for mPrPp(23–50) (which would facilitate initial
contact with the negatively charged membranes via electro-
static interactions) this is obviously not the major determining
factor for the membrane activities investigated in the present
study.
The mPrPp(1–28) has the theoretical ability to form an
amphipathic helix based on helical wheel projections and may
therefore, in parallel to the endocytotic mechanism, internalize
by transient pore formation or disruption of the bilayer ac-
cording to the carpeting model. These latter mechanisms are
related to what has been described earlier for anti-microbial
peptides among others [27,28]. Since the CD-data clearly shows
a mixture of induced α-helix and β-sheet for mPrPp(1–28)
when interacting with the LUVs, we cannot rule out these as
complementary mechanisms. The presence of an unprocessed
signal peptide in the PrP may cause not only toxicity through
212 K. Oglęcka et al. / Biochimica et Biophysica Acta 1778 (2008) 206–213transient pore formation, but also mediate aggregation that
might lead to the structure conversion of PrPC to PrPSc. In
addition, the CPP-like activity of the N-terminus of the un-
processed protein, could be important in the transmission pro-
cess of TSE diseases. Binding to negatively charged cell surface
heparan sulphates, would provide the main route of entry to the
cell by endocytosis [16]. How PrP conversion takes place is still
unknown, but several studies suggest that lipid rafts might play
a key role in the process [29] and cholesterol depletion has been
shown to decrease conversion of PrPC to PrPSc [30]. An in-
fection propagation by direct cell membrane contacts has also
been proposed [31]. It is worth noting that among the common
“amyloid” related proteins, only PrP has a hydrophobic signal
sequence directly followed by a basic sequence [32]—the
combination of which should be responsible for the CPP-like
property of this domain.
In conclusion, the NLS-like (23–28) sequence KKRPKP in
the prion protein requires addition of a hydrophobic segment
like an uncleaved signal peptide (1–22) sequence to bring about
potent membrane perturbing activities. The addition of the more
hydrophilic (29–50) peptide sequence does not mediate this
activity. The results indicate that a prion protein with an un-
cleaved signal sequence in its unstructured N-terminus should
be much more perturbing to cellular membranes than its prop-
erly processed form without signal peptide.
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